-
1
-
-
0036559896
-
Papillomaviruses and cancer: From basic studies to clinical application
-
zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-350
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 342-350
-
-
Zur Hausen, H.1
-
2
-
-
42149123438
-
Therapeutic human papillomavirus vaccines: Current clinical trials and future directions
-
DOI 10.1517/14712598.8.4.421
-
Hung C, Ma B, Monie A, Tsen S, Wu T. Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin BiolTher 2008;8:421-439 (Pubitemid 351570408)
-
(2008)
Expert Opinion on Biological Therapy
, vol.8
, Issue.4
, pp. 421-439
-
-
Hung, C.-F.1
Ma, B.2
Monie, A.3
Tsen, S.-W.4
Wu, T.-C.5
-
4
-
-
0029041842
-
Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
-
International biological study on cervical cancer (IBSCC) Study Group
-
Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87: 796-802.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 796-802
-
-
Bosch, F.X.1
Manos, M.M.2
Munoz, N.3
-
5
-
-
0037153042
-
A controlled trial of a human papillomavirus type 16 vaccine
-
DOI 10.1056/NEJMoa020586
-
Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N EnglJ Med 2002;347:1645-1651 (Pubitemid 35340782)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.21
, pp. 1645-1651
-
-
Koutsky, L.A.1
Ault, K.A.2
Wheeler, C.M.3
Brown, D.R.4
Barr, E.5
Alvarez, F.B.6
Chiacchierini, L.M.7
Jansen, K.U.8
-
6
-
-
14844355235
-
Human papillomavirus vaccine: History, immunology, current status, and future prospects
-
DOI 10.1097/01.grf.0000151585.16357.e6
-
Padilla-Paz LA. Human papillomavirus vaccine: history, immunology, current status, and future prospects. Clin Obstet Gynecol 2005;48:226-240 (Pubitemid 40354392)
-
(2005)
Clinical Obstetrics and Gynecology
, vol.48
, Issue.1
, pp. 226-240
-
-
Padilla-Paz, L.A.1
-
7
-
-
9444268103
-
Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology
-
Tsukui T, Hildesheim A, Schiffman MH, et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus- derived peptides: correlation with cervical pathology. Cancer Res 1996;56:3967-3974 (Pubitemid 26284746)
-
(1996)
Cancer Research
, vol.56
, Issue.17
, pp. 3967-3974
-
-
Tsukui, T.1
Hildesheim, A.2
Schiffman, M.H.3
Lucci III, J.4
Contois, D.5
Lawler, P.6
Rush, B.B.7
Lorincz, A.T.8
Corrigan, A.9
Burk, R.D.10
Qu, W.11
Marshall, M.A.12
Mann, D.13
Carrington, M.14
Clerici, M.15
Shearer, G.M.16
Carbone, D.P.17
Scott, D.R.18
Houghten, R.A.19
Berzofsky, J.A.20
more..
-
8
-
-
0035853103
-
Intralymphatic immunization enhances DNA vaccination
-
DOI 10.1073/pnas.051630798
-
Maloy KJ, Erdmann I, Basch V, et al. Intralymphatic immunization enhances DNA vaccination. Proc NatlAcad Sci U S A 2001;98:3299-3303 (Pubitemid 32220840)
-
(2001)
Proceedings of the National Academy of Sciences of the United States of America
, vol.98
, Issue.6
, pp. 3299-3303
-
-
Maloy, K.J.1
Erdmann, I.2
Basch, V.3
Sierro, S.4
Kramps, T.A.5
Zinkernagel, R.M.6
Oehen, S.7
Kundig, T.M.8
-
9
-
-
20844455173
-
Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration
-
DOI 10.1002/eji.200526124
-
von Beust BR, Johansen P, Smith KA, Bot A, Storni T, Kundig TM. Improving the therapeutic index of CpG oligodeoxynucleotides by intralymphatic administration. Eur J Immunol 2005; 35:1869-1876 (Pubitemid 40862335)
-
(2005)
European Journal of Immunology
, vol.35
, Issue.6
, pp. 1869-1876
-
-
Von Beust, B.R.1
Johansen, P.2
Smith, K.A.3
Bot, A.4
Storni, T.5
Kundig, T.M.6
-
10
-
-
63449140410
-
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides
-
Smith KA, Tam VL, Wong RM, et al. Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides. Vaccine 2009;27:2603-2615
-
(2009)
Vaccine
, vol.27
, pp. 2603-2615
-
-
Smith, K.A.1
Tam, V.L.2
Wong, R.M.3
-
11
-
-
0027320440
-
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
-
Feltkamp MC, Smits HL, Vierboom MP, et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993;23:2242-2249
-
(1993)
Eur J Immunol
, vol.23
, pp. 2242-2249
-
-
Feltkamp, M.C.1
Smits, H.L.2
Vierboom, M.P.3
-
12
-
-
0029030393
-
Fibroblasts as efficient antigen-presenting cells in lymphoid organs
-
Kundig TM, Bachmann MF, DiPaolo C, et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995;268:1343-1347
-
(1995)
Science
, vol.268
, pp. 1343-1347
-
-
Kundig, T.M.1
Bachmann, M.F.2
DiPaolo, C.3
-
13
-
-
44949242538
-
Phase 1 Trial of intranodal injection of a Melan-A/ MART-1 DNA plasmid vaccine in patients with stage IV melanoma
-
Weber J, Boswell W, Smith J, et al. Phase 1 Trial of intranodal injection of a Melan-A/ MART-1 DNA plasmid vaccine in patients with stage IV melanoma. J Immunother 2008; 31:215-223
-
(2008)
J Immunother
, vol.31
, pp. 215-223
-
-
Weber, J.1
Boswell, W.2
Smith, J.3
-
14
-
-
0036801463
-
Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination
-
DOI 10.1172/JCI200215536
-
Wang L, Smith D, Bot S, Dellamary L, Bloom A, Bot A. Noncoding RNA danger motifs bridge innate and adaptive immunity and are potent adjuvants for vaccination. J Clin Invest 2002;110: 1175-1184 (Pubitemid 35215898)
-
(2002)
Journal of Clinical Investigation
, vol.110
, Issue.8
, pp. 1175-1184
-
-
Wang, L.1
Smith, D.2
Bot, S.3
Dellamary, L.4
Bloom, A.5
Bot, A.6
-
15
-
-
34249677845
-
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
-
DOI 10.1038/nm1589, PII NM1589
-
Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007;13:552-559 (Pubitemid 46830615)
-
(2007)
Nature Medicine
, vol.13
, Issue.5
, pp. 552-559
-
-
Kanzler, H.1
Barrat, F.J.2
Hessel, E.M.3
Coffman, R.L.4
-
16
-
-
34248194231
-
Tregs and rethinking cancer immunotherapy
-
CurielTJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117:1167-1174
-
(2007)
J Clin Invest
, vol.117
, pp. 1167-1174
-
-
Curiel, T.J.1
-
17
-
-
0035328683
-
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
-
Machiels JPH, Reilly RT, Emens LA, et al. Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage- colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001;61:3689-3697
-
(2001)
Cancer Res
, vol.61
, pp. 3689-3697
-
-
Machiels, J.P.H.1
Reilly, R.T.2
Emens, L.A.3
-
18
-
-
1642378018
-
+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
-
DOI 10.1002/eji.200324181
-
Ghiringhelli F, Larmonier N, Schmitt E, et al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 2004;34:336-344 (Pubitemid 39255944)
-
(2004)
European Journal of Immunology
, vol.34
, Issue.2
, pp. 336-344
-
-
Ghiringhelli, F.1
Larmonier, N.2
Schmitt, E.3
Parcellier, A.4
Cathelin, D.5
Garrido, C.6
Chauffert, B.7
Solary, E.8
Bonnotte, B.9
Martin, F.10
-
19
-
-
33644531900
-
Chemoimmunotherapy of tumors: Cyclophosphamide synergizes with exosome based vaccines
-
Taieb J, Chaput N, Schartz N, et al. Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines. J Immunol 2006;176:2722-2729
-
(2006)
J Immunol
, vol.176
, pp. 2722-2729
-
-
Taieb, J.1
Chaput, N.2
Schartz, N.3
-
20
-
-
26644448965
-
Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model
-
DOI 10.1016/j.vaccine.2005.04.049, PII S0264410X05006274
-
Vambutas A, DeVoti J, Nouri M, et al. Therapeutic vaccination with papillomavirus E6 and E7 long peptides results in the control of both established virus-induced lesions and latently infected sites in a pre-clinical cottontail rabbit papillomavirus model. Vaccine 2005;23: 5271-5280 (Pubitemid 41443433)
-
(2005)
Vaccine
, vol.23
, Issue.45
, pp. 5271-5280
-
-
Vambutas, A.1
Devoti, J.2
Nouri, M.3
Drijfhout, J.W.4
Lipford, G.B.5
Bonagura, V.R.6
Van Der Burg, S.H.7
Melief, C.J.M.8
-
21
-
-
0032889347
-
Phase I safety and antigenicity of TA-GW: A recombinant HPV6 L2E7 vaccine for the treatment of genital warts
-
Thompson HS, Davies ML, Holding FP, et al. Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts. Vaccine 1999;17: 40-49
-
(1999)
Vaccine
, vol.17
, pp. 40-49
-
-
Thompson, H.S.1
Davies, M.L.2
Holding, F.P.3
-
22
-
-
33744505292
-
Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion
-
DOI 10.1016/j.vaccine.2006.03.079, PII S0264410X06003963
-
Daftarian P, Mansour M, Benoit AC, et al. Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T help fusion peptide in a water-in-oilemul sion. Vaccine 2006;24:5235-5244 (Pubitemid 43818188)
-
(2006)
Vaccine
, vol.24
, Issue.24
, pp. 5235-5244
-
-
Daftarian, P.1
Mansour, M.2
Benoit, A.C.3
Pohajdak, B.4
Hoskin, D.W.5
Brown, R.G.6
Kast, W.M.7
-
23
-
-
33846921847
-
Listeria based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse modelof cancer
-
Souders NC, Sewell DA, Pan ZK, et al. Listeria based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse modelof cancer. Cancer Immun 2007;7:2.
-
(2007)
Cancer Immun
, vol.7
, pp. 2
-
-
Souders, N.C.1
Sewell, D.A.2
Pan, Z.K.3
-
24
-
-
84984552535
-
Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin
-
DOI 10.1016/j.vaccine.2004.03.057, PII S0264410X04003299
-
Hsieh CJ, Kim TW, Hung CF, et al. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin. Vaccine 2004;22:3993-4001. (Pubitemid 39208763)
-
(2004)
Vaccine
, vol.22
, Issue.29-30
, pp. 3993-4001
-
-
Hsieh, C.-J.1
Kim, T.W.2
Hung, C.-F.3
Juang, J.4
Moniz, M.5
Boyd, D.A.K.6
He, L.7
Chen, P.-J.8
Chen, C.-H.9
Wu, T.-C.10
-
25
-
-
0034802089
-
Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site
-
Lamikanra A, Pan ZK, Isaacs SN, Wu TC, Paterson YJ. Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site. Virol 2001;75:9654-9664
-
(2001)
Virol
, vol.75
, pp. 9654-9664
-
-
Lamikanra, A.1
Pan, Z.K.2
Isaacs, S.N.3
Wu, T.C.4
Paterson, Y.J.5
-
26
-
-
0030068375
-
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
-
Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21-26
-
(1996)
Cancer Res
, vol.56
, pp. 21-26
-
-
Lin, K.Y.1
Guarnieri, F.G.2
Staveley-O'Carroll, K.F.3
-
27
-
-
0346995215
-
Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection
-
DOI 10.1128/JVI.78.1.116-123.2004
-
Brandsma JL, Shlyankevich M, Zhang L, et al. Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection. J Virol 2004;78:116-123 (Pubitemid 37549724)
-
(2004)
Journal of Virology
, vol.78
, Issue.1
, pp. 116-123
-
-
Brandsma, J.L.1
Shlyankevich, M.2
Zhang, L.3
Slade, M.D.4
Goodwin, E.C.5
Peh, W.6
Deisseroth, A.B.7
-
28
-
-
34247626477
-
Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice
-
DOI 10.1007/s00262-006-0247-2
-
Gomez-Gutierrez JG, Elpek KG, Montes de Oca- Luna R, Shirwan H, Sam Zhou H, McMasters KM. Vaccination with an adenoviralvector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice. Cancer ImmunolImmuno ther 2007;56:997-1007. (Pubitemid 46675294)
-
(2007)
Cancer Immunology, Immunotherapy
, vol.56
, Issue.7
, pp. 997-1007
-
-
Gomez-Gutierrez, J.G.1
Elpek, K.G.2
Montes De Oca-Luna, R.3
Shirwan, H.4
Sam Zhou, H.5
McMasters, K.M.6
-
29
-
-
0034306991
-
Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell based vaccination against human papillomavirus 16-induced tumor cells in a murine model
-
Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, CurielD T. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Res 2000;60:5456-5463
-
(2000)
Cancer Res
, vol.60
, pp. 5456-5463
-
-
Tillman, B.W.1
Hayes, T.L.2
DeGruijl, T.D.3
Douglas, J.T.4
Curield, T.5
-
30
-
-
0034061398
-
Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity
-
DOI 10.1038/sj/gt/3301160
-
Wang TL, Ling M, Shih IM, et al. Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity. Gen Ther 2000;7:726-733. (Pubitemid 30255753)
-
(2000)
Gene Therapy
, vol.7
, Issue.9
, pp. 726-733
-
-
Wang, T.-L.1
Ling, M.2
Shih, I.-M.3
Pham, T.4
Pai, S.I.5
Lu, Z.6
Kurman, R.J.7
Pardoll, D.M.8
Wu, T.-C.9
-
31
-
-
23744472184
-
Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope
-
DOI 10.1038/sj.gt.3302519
-
Huang CH, Peng S, He L, et al. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope. Gene Ther 2005;12:1180-1186 (Pubitemid 41136312)
-
(2005)
Gene Therapy
, vol.12
, Issue.15
, pp. 1180-1186
-
-
Huang, C.-H.1
Peng, S.2
He, L.3
Tsai, Y.-C.4
Boyd, D.A.K.5
Hansen, T.H.6
Wu, T.-C.7
Hung, C.-F.8
-
32
-
-
0034063322
-
Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
-
DOI 10.1002/(SICI)1097-0215(20000601)86:5<725::AID-IJC19>3.0.CO;2-K
-
Chang EY, Chen CH, Ji H, et al. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine. Int J Cancer 2000;86:725-730 (Pubitemid 30249886)
-
(2000)
International Journal of Cancer
, vol.86
, Issue.5
, pp. 725-730
-
-
Chang, E.Y.1
Chen, C.-H.2
Ji, H.3
Wang, T.-L.4
Hung, K.5
Lee, B.P.6
Huang, A.Y.C.7
Kurman, R.J.8
Pardoll, D.M.9
Wu, T.-C.10
-
33
-
-
24944478531
-
Leveraging the activity of tumor vaccines with cytotoxic chemotherapy
-
DOI 10.1158/0008-5472.CAN-05-1797
-
Emens LA, Jaffee EM. Leveraging the activity of tumor vaccines with cytotoxic chemotherapy. Cancer Res 2005;65:8059-8064 (Pubitemid 41330564)
-
(2005)
Cancer Research
, vol.65
, Issue.18
, pp. 8059-8064
-
-
Emens, L.A.1
Jaffee, E.M.2
-
34
-
-
66249095192
-
Cyclophosphamide augments antitumor immunity: Studies in an autochthonous prostate cancer model
-
Wada S, Yoshimura K, Hipkiss EL, et al. Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model. Cancer Res 2009;69:4309-4318
-
(2009)
Cancer Res
, vol.69
, pp. 4309-4318
-
-
Wada, S.1
Yoshimura, K.2
Hipkiss, E.L.3
|